Study Uncovers Persistent Health Risks in HIV Patients Despite Effective Treatment

A recent study has disclosed that a considerable number of individuals living with HIV (PWH), who are on long-term antiretroviral therapy, continue to face immune and metabolic complications even though their viral loads are successfully suppressed. This research underscores the urgent need for tailored precision medicine strategies to enhance the long-term health outcomes for these patients.

Despite the effectiveness of antiretroviral therapy in controlling the virus, the study suggests that it does not fully mitigate other health risks associated with HIV. These findings could influence future treatment protocols and healthcare approaches for managing HIV.

Date: February 28, 2025

Newsflash | Powered by GeneOnline AI

Related posts:

Cryptic Antigen Identified as New Immunotherapy Target for Ovarian Cancer New Skin Disease Identified Through Advanced Diagnostic Technology Virginia’s Insurance Marketplace Extends Open Enrollment Deadline: A Detailed Report Amy Schumer’s Journey with Cushing Syndrome

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline